Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0884-2022Class II

Alinity m HBV AMP Kit (US and CE)

Abbott Molecular, Inc. / initiated 2022-03-04 / Open, Classified

Abbott Molecular, Inc. began a recall of Alinity m HBV AMP Kit (US and CE) on . FDA classified it as Class II and gives the reason as "There is a potential for misquantitation high results for negative samples". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0884-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Abbott Molecular, Inc.
Product
Alinity m HBV AMP Kit (US and CE)
Product code
MKT Hepatitis Viral B Dna Detection
Reason for recall
There is a potential for misquantitation high results for negative samples.
FDA root cause
Under Investigation by firm
Action
On March 4, 2022, Abbott Molecular issued an Urgent Field Safety Notice / Field Correction Recall Notice, Urgent Field Safety Notice, and Dear Health Care Provider letter to all customers who received the Alinity m HBV Amp Kits (List Number 08N47-095 Lot Numbers 519756, 523799, 524361 and List Number 08N47-090 Lot Numbers 519755 520957, 522137, 523798, and 524059). Consignees are asked to follow the necessary actions outlined in the letter and complete and return the Customer Reply Form. The results from the Alinity m HBV assay must be interpreted within the context of all relevant clinical and laboratory findings. If results are inconsistent with patient history and other diagnostics through patient monitoring, a retest of the same sample should be considered. 100% of customers are requested to return to Abbott a Customer Reply Form acknowledging receipt and understanding, and/or a request for assistance. Abbott personnel will follow up with customers by e-mailing and or follow-up visits/phone calls. The firm issued a second Urgent Field Safety Notice / Field Correction Recall notice on 01/13/2023 to consignees that received the newly identified lot numbers: (List Number 08N47-095 Lot Numbers 381583, 529391, 529687, 530273, 531598 and List Number 08N47-090 Lot Numbers 380963, 380979, 381021, 529378, 529686, 530272, 531189, 531596).
Quantity in commerce
4966 kits, updated 101/17/2023
Distribution
US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam
Product codes and lots
List Numbers: 1) 08N47-095 (US); Lots: 519756, 523799, and 524361, Updated to add: 381583, 529391, 529687, 530273, 531598; 2) 08N47-090 (CE); Lots: 519755, 520957, 522137, 523798, and 524059, Updated to add: 380963, 380979, 381021, 529378, 529686, 530272, 531189, 531596

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0884-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0883-2022Class IIOngoingVoluntary: Firm initiated
Z-0884-2022Class IIOngoingVoluntary: Firm initiated